Mucopolysaccharidosis

Mucopolysaccharidosis are group of inherited metabolic diseases caused by the absence or malfunctioning of lysosomal enzymes resulting in accumulation of glycosaminoglycans. Over time this accumulation damages cells, tissues, and organs. There are seven types of MPS and 13 subtypes that are associat...

Full description

Bibliographic Details
Main Authors: Kusumitha Bhakthaganesh, Manumuraleekrishna, Murugesan Vanathi, Shifa Ahmed, Noopur Gupta, Radhika Tandon
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=443;epage=450;aulast=Bhakthaganesh
_version_ 1797226190978678784
author Kusumitha Bhakthaganesh
Manumuraleekrishna
Murugesan Vanathi
Shifa Ahmed
Noopur Gupta
Radhika Tandon
author_facet Kusumitha Bhakthaganesh
Manumuraleekrishna
Murugesan Vanathi
Shifa Ahmed
Noopur Gupta
Radhika Tandon
author_sort Kusumitha Bhakthaganesh
collection DOAJ
description Mucopolysaccharidosis are group of inherited metabolic diseases caused by the absence or malfunctioning of lysosomal enzymes resulting in accumulation of glycosaminoglycans. Over time this accumulation damages cells, tissues, and organs. There are seven types of MPS and 13 subtypes that are associated with multiple organ systems, such as the respiratory, liver, spleen, central nervous systems, arteries, skeletons, eyes, joints, ears, skin, and/or teeth. The various types share some common ocular features that differ in terms of the severity of the affection. Visual loss in MPS patients is varied and can be due to corneal clouding, glaucoma, retinopathy, and optic neuropathy. The primary focus of this review is on changes in the cornea and anterior segment in MPS patients, including clinical and novel investigative modalities, current surgical management, effects of systemic therapy like hematopoietic stem cell transplants (HSCT)and enzyme replacement therapy (ERT), as well as significant research developments.
first_indexed 2024-04-24T14:20:59Z
format Article
id doaj.art-effaa58fe7614985a759093c4f8f13f8
institution Directory Open Access Journal
issn 2211-5056
2211-5072
language English
last_indexed 2024-04-24T14:20:59Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Taiwan Journal of Ophthalmology
spelling doaj.art-effaa58fe7614985a759093c4f8f13f82024-04-03T06:45:05ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722023-01-0113444345010.4103/tjo.TJO-D-23-00137MucopolysaccharidosisKusumitha BhakthaganeshManumuraleekrishnaMurugesan VanathiShifa AhmedNoopur GuptaRadhika TandonMucopolysaccharidosis are group of inherited metabolic diseases caused by the absence or malfunctioning of lysosomal enzymes resulting in accumulation of glycosaminoglycans. Over time this accumulation damages cells, tissues, and organs. There are seven types of MPS and 13 subtypes that are associated with multiple organ systems, such as the respiratory, liver, spleen, central nervous systems, arteries, skeletons, eyes, joints, ears, skin, and/or teeth. The various types share some common ocular features that differ in terms of the severity of the affection. Visual loss in MPS patients is varied and can be due to corneal clouding, glaucoma, retinopathy, and optic neuropathy. The primary focus of this review is on changes in the cornea and anterior segment in MPS patients, including clinical and novel investigative modalities, current surgical management, effects of systemic therapy like hematopoietic stem cell transplants (HSCT)and enzyme replacement therapy (ERT), as well as significant research developments.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=443;epage=450;aulast=Bhakthaganeshanterior segment optical coherence tomographycorneal opacification measurement scoreenzyme replacement therapyglycosaminoglycanshematopoietic stem cell transplantin vivo confocal microscopymucopolysaccharidosesultrasound biomicroscopy
spellingShingle Kusumitha Bhakthaganesh
Manumuraleekrishna
Murugesan Vanathi
Shifa Ahmed
Noopur Gupta
Radhika Tandon
Mucopolysaccharidosis
Taiwan Journal of Ophthalmology
anterior segment optical coherence tomography
corneal opacification measurement score
enzyme replacement therapy
glycosaminoglycans
hematopoietic stem cell transplant
in vivo confocal microscopy
mucopolysaccharidoses
ultrasound biomicroscopy
title Mucopolysaccharidosis
title_full Mucopolysaccharidosis
title_fullStr Mucopolysaccharidosis
title_full_unstemmed Mucopolysaccharidosis
title_short Mucopolysaccharidosis
title_sort mucopolysaccharidosis
topic anterior segment optical coherence tomography
corneal opacification measurement score
enzyme replacement therapy
glycosaminoglycans
hematopoietic stem cell transplant
in vivo confocal microscopy
mucopolysaccharidoses
ultrasound biomicroscopy
url http://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=4;spage=443;epage=450;aulast=Bhakthaganesh
work_keys_str_mv AT kusumithabhakthaganesh mucopolysaccharidosis
AT manumuraleekrishna mucopolysaccharidosis
AT murugesanvanathi mucopolysaccharidosis
AT shifaahmed mucopolysaccharidosis
AT noopurgupta mucopolysaccharidosis
AT radhikatandon mucopolysaccharidosis